43 drugs in pipeline from 10 companies
43
Drugs in Pipeline
10
Companies
2
Upcoming Catalysts
28
Phase 3 Trials
OTX-TKI (axitinib implant) Phase 3 Results Expected
OTX-TKI (axitinib implant) • Neovascular Age-Related Macular Degeneration
Aldeyra Therapeutics, Inc.
OCULAR THERAPEUTIX, INC
EyePoint Pharmaceuticals, Inc.
Kodiak Sciences Inc
Oyster Point Pharma, Inc.
Clearside Biomedical, Inc.
Outlook Therapeutics, Inc.
Apellis Pharmaceuticals, Inc.
Aurinia Pharmaceuticals Inc.
Kala Pharmaceuticals, Inc.
